Nitto https://www.nitto.com/eu/it Nitto What's New it Fri, 10 Sep 2021 17:00:00 +0100 Nitto Logo https://www.nitto.com/eu/it https://www.nitto.com/common/img/logo.png Pubblicazione del piano di gestione a medio termine per l’anno fiscale dal 2021 al 2023, “Nitto Beyond 2023” https://www.nitto.com/eu/it/about_us/concepts/management_plans/ Fri, 10 Sep 2021 17:00:00 +0100 Company News Collaborazione tra Nitto, Astellas e M.Heart per fornire un servizio di analisi ECG https://www.nitto.com/eu/it/press/2021/0902.jsp Una soluzione completa per il rilevamento precoce della fibrillazione atriale grazie a un dispositivo monouso per ECG dinamico secondo Holter e a un servizio di analisi basato sull’IA Thu, 02 Sep 2021 15:00:00 +0100 Company News Nitto parteciperà per la prima volta alla Milano Design Week 2021 https://www.nitto.com/eu/it/press/2021/0705.jsp RAYCREA, la nuova tecnologia di regolazione della luce Mon, 05 Jul 2021 13:00:00 +0100 Company News Shareholders' Meeting has been updated https://www.nitto.com/ir/shareholdersmeeting/ Fri, 18 Jun 2021 17:00:00 +0100 Investor Relations 2021/Jul/26 Announcement of Financial Results for 1Q, FY2021 https://www.nitto.com/ir/calendar/ Tue, 15 Jun 2021 16:00:00 +0100 Investor Relations Raggiungimento dell’obiettivo intermedio relativo al contratto di licenza di ND-L02-s0201 https://www.nitto.com/eu/it/press/2021/0615.jsp Sviluppo di ND-L02-s0201, un farmaco siRNA HSP47 per la fibrosi Tue, 15 Jun 2021 15:00:00 +0100 Company News Investor Relations Shareholders' Meeting has been updated https://www.nitto.com/ir/shareholdersmeeting/ Fri, 28 May 2021 17:00:00 +0100 Investor Relations Announcement of Financial Results of FY2020 https://www.nitto.com/ir/library/result/ Mon, 26 Apr 2021 16:00:00 +0100 Investor Relations Nitto rafforza il settore della produzione terapeutica a base di oligonucleotidi https://www.nitto.com/eu/it/press/2021/0331.jsp Dallo sviluppo iniziale alla produzione commerciale Wed, 31 Mar 2021 16:00:00 +0100 Company News 2021/Apr/26 Announcement of Financial Results of FY2020 https://www.nitto.com/ir/calendar/ Mon, 15 Mar 2021 16:01:00 +0100 Investor Relations Announcement of Financial Results 3Q, FY2020 https://www.nitto.com/ir/library/result/ Tue, 26 Jan 2021 16:00:00 +0100 Investor Relations 2021/Jan/26 Announcement of Financial Results for 3Q, FY2020 https://www.nitto.com/jp/en/ir/calendar/ Tue, 15 Dec 2020 16:00:00 +0100 Investor Relations Il marchio di nastri decorativi “HARU stuck-on design” ottiene un riconoscimento internazionale con un German Design Award 2021 https://www.nitto.com/eu/it/press/2020/1110.jsp Tue, 10 Nov 2020 15:00:00 +0100 Company News Announcement of Financial Results 2Q, FY2020 https://www.nitto.com/ir/library/result/ Mon, 26 Oct 2020 16:00:00 +0100 Investor Relations Auguri per il 20º anniversario di Nitto Denko Himawari Corporation https://www.nitto.com/eu/it/press/2020/1016.jsp Fri, 16 Oct 2020 08:00:00 +0100 Company News Nitto Belgium among top 5% performers worldwide https://www.nitto.com/eu/it/press/2020/0916.jsp Fri, 09 Oct 2020 00:00:01 +0100 Company News 2020/Oct/26 Announcement of Financial Results 2Q, FY2020 https://www.nitto.com/jp/en/ir/calendar/ Fri, 18 Sep 2020 16:00:00 +0100 Investor Relations Nitto estende la partnership con ATP fino al 2025 https://www.nitto.com/eu/it/press/2020/0910.jsp Thu, 10 Sep 2020 18:00:00 +0100 Company News Il primo vetro ultrasottile al mondo(*) dotato di pellicola polarizzante sviluppato in collaborazione con Nippon Electric Glass https://www.nitto.com/eu/it/press/2020/0728.jsp Tue, 28 Jul 2020 15:00:00 +0100 Company News Announcement of Financial Results 1Q, FY2020 https://www.nitto.com/ir/library/result/ Mon, 27 Jul 2020 16:01:00 +0100 Investor Relations 2020/Jul/27 Announcement of Financial Results 1Q, FY2020 https://www.nitto.com/ir/calendar/ Fri, 26 Jun 2020 13:00:00 +0100 Investor Relations 10-year Summary has been updated https://www.nitto.com/ir/finance/invest/ Fri, 26 Jun 2020 10:00:00 +0100 Investor Relations 4,900 face masks donated to Policlinico Hospital in Milan, Italy https://www.nitto.com/eu/it/press/2020/0622.jsp Tue, 23 Jun 2020 00:12:36 +0100 Company News Shareholders' Meeting has been updated https://www.nitto.com/ir/shareholdersmeeting/ Fri, 19 Jun 2020 17:00:00 +0100 Investor Relations La nostra risposta alla diffusione del COVID-19 https://www.nitto.com/eu/it/press/2020/0616.jsp Tue, 16 Jun 2020 17:00:00 +0100 Company News Shareholders' Meeting has been updated https://www.nitto.com/ir/shareholdersmeeting/ Fri, 29 May 2020 17:00:00 +0100 Investor Relations Announcement of Financial Results of FY2019 https://www.nitto.com/ir/library/result/ Mon, 27 Apr 2020 16:01:00 +0100 Investor Relations Belgian companies join forces to help ease healthcare burden https://www.nitto.com/eu/it/press/2020/0423.jsp Thu, 23 Apr 2020 09:00:00 +0100 Product 2020/Apr/27 Announcement of Financial Results of FY2019 https://www.nitto.com/ir/calendar/ Tue, 14 Apr 2020 16:01:00 +0100 Investor Relations Avvio dello studio clinico multiregionale di fase 2 su ND-L02-s0201 per la fibrosi polmonare idiopatica (IPF) in Giappone https://www.nitto.com/eu/it/press/2020/0302.jsp Sviluppo di ND-L02-s0201 con indicazione per la fibrosi polmonare idiopatica Mon, 02 Mar 2020 15:00:00 +0100 Company News Attività di beneficenza in occasione del torneo Nitto ATP Finals a sostegno dell’UNICEF https://www.nitto.com/eu/it/press/2020/0214.jsp Fri, 14 Feb 2020 09:00:00 +0100 Company News Notice of Act of Misconduct by Members of a Nitto Subsidiary https://www.nitto.com/ir/library/disclosure/ Mon, 27 Jan 2020 16:02:00 +0100 Investor Relations Announcement of Financial Results 3Q, FY2019 https://www.nitto.com/ir/library/result/ Mon, 27 Jan 2020 16:01:00 +0100 Investor Relations Resolution Regarding Share Repurchase https://www.nitto.com/ir/library/disclosure/ Mon, 27 Jan 2020 16:00:00 +0100 Investor Relations Report sui programmi di beneficenza per le Nitto ATP Finals https://www.nitto.com/eu/it/press/2020/0117.jsp Mon, 27 Jan 2020 09:00:00 +0100 Company News 2020/Jan/27 Announcement of Financial Results for 3Q, FY2019 https://www.nitto.com/ir/calendar/ Wed, 25 Dec 2019 16:00:00 +0100 Investor Relations Creazione della sede centrale di Tokyo e consolidamento dell’ufficio commerciale di Tokyo https://www.nitto.com/eu/it/press/2019/1203.jsp Tue, 03 Dec 2019 15:00:00 +0100 Company News 「令和元年台風第19号」に対する支援について Fri, 29 Nov 2019 17:00:00 +0100 Company News Announcement of Financial Results 2Q, FY2019 https://www.nitto.com/ir/library/result/ Mon, 28 Oct 2019 16:00:00 +0100 Investor Relations Notice of Revisions to the Consolidated Financial Forecasts https://www.nitto.com/ir/library/disclosure/ Wed, 23 Oct 2019 10:00:00 +0100 Investor Relations 2019/Oct/28 Announcement of Financial Results for 2Q, FY2019 https://www.nitto.com/ir/calendar/ Wed, 25 Sep 2019 16:00:00 +0100 Investor Relations Announcement of Financial Results 1Q, FY2019 https://www.nitto.com/ir/library/result/ Fri, 26 Jul 2019 16:00:00 +0100 Investor Relations Alleanza con Drug Discovery Gateway Investment Limited Partnership per accelerare la commercializzazione di un nuovo sistema terapeutico transdermico ("PassPort System") https://www.nitto.com/eu/it/press/2019/0719.jsp Fri, 19 Jul 2019 12:00:00 +0100 Company News FOAM EXPO Europe, dal 10 al 12 settembre 2019 a Stoccarda, in Germania https://www.nitto.com/eu/it/topics/2019/0717.jsp Wed, 17 Jul 2019 09:50:53 +0100 Trade Show Shareholders' Meeting has been updated https://www.nitto.com/ir/shareholdersmeeting/ Fri, 21 Jun 2019 17:00:00 +0100 Investor Relations Sumitomo Dainippon Pharma e Nitto Denko annunciano l’approvazione in Giappone della formulazione dell’antipsicotico atipico LONASEN™ su cerotto https://www.nitto.com/eu/it/press/2019/0618.jsp Tue, 18 Jun 2019 15:00:00 +0100 Company News Annual Investors' Meeting Update - Webcast Replay https://www.nitto.com/ir/library/meeting/ Wed, 12 Jun 2019 16:00:00 +0100 Investor Relations Presentazione di Bisono™ Tape 2mg, un cerotto transdermico contenente β1-bloccante https://www.nitto.com/eu/it/press/2019/0607.jsp Fri, 07 Jun 2019 15:00:00 +0100 Company News Company Information Meeting has been updated https://www.nitto.com/ir/library/meeting/ Fri, 31 May 2019 17:30:00 +0100 Investor Relations Shareholders' Meeting has been updated https://www.nitto.com/ir/shareholdersmeeting/ Fri, 31 May 2019 17:00:00 +0100 Investor Relations Announcement of Financial Results of FY2018 https://www.nitto.com/ir/library/result/ Fri, 26 Apr 2019 16:01:00 +0100 Investor Relations Notice Regarding Change in Appointment of Representative Director https://www.nitto.com/ir/library/disclosure/ Fri, 26 Apr 2019 16:00:00 +0100 Investor Relations Istituito un dipartimento di ricerca collaborativa per lo sviluppo di nuovi farmaci a base di acidi nucleici https://www.nitto.com/eu/it/press/2019/0418.jsp Nitto Denko e Osaka International Cancer Institute Thu, 18 Apr 2019 16:00:00 +0100 Company News 2019/Apr/26 Announcement of Financial Results for Fiscal 2018 https://www.nitto.com/ir/calendar/ Fri, 22 Mar 2019 16:00:00 +0100 Investor Relations Notice Concerning Basic Policy on the Holding and Cancellation of Treasury Shares https://www.nitto.com/ir/library/disclosure/ Thu, 28 Feb 2019 16:00:00 +0100 Investor Relations Attività di beneficenza Nitto ATP Finals a sostegno dell'UNICEF https://www.nitto.com/eu/it/press/2019/0225.jsp Wed, 27 Feb 2019 09:00:00 +0100 Company News Nitto Belgium sposta 500 container dal trasporto stradale a quello fluviale attraverso il deposito di Maersk presso il porto di Genk https://www.nitto.com/eu/it/topics/2019/0214.jsp Thu, 14 Feb 2019 15:28:46 +0100 Company News Announcement of Financial Results 3Q, FY2018 https://www.nitto.com/ir/library/result/ Thu, 31 Jan 2019 16:00:00 +0100 Investor Relations Per l’ottavo anno consecutivo, Nitto entra nella Derwent Top 100 Global Innovators 2018-19, distinguendosi come una delle 100 aziende più innovatrici al mondo https://www.nitto.com/eu/it/press/2019/0123.jsp Wed, 23 Jan 2019 15:00:00 +0100 Company News Bisono™Tape, un cerotto transdermico con un betabloccante specifico per i recettori β1 per il trattamento della fibrillazione atriale, ottiene nuove approvazioni in Giappone per il dosaggio da 2 mg e le formulazioni migliorate da 4 mg e 8 mg https://www.nitto.com/eu/it/press/2019/0108.jsp Tue, 08 Jan 2019 15:00:00 +0100 Company News Announcement of Financial Results for 3Q, FY2018 https://www.nitto.com/ir/calendar/ Tue, 25 Dec 2018 16:00:00 +0100 Investor Relations Un resoconto dei programmi di beneficenza collegati alle Nitto ATP Finals https://www.nitto.com/eu/it/press/2018/1221.jsp Fri, 21 Dec 2018 15:00:00 +0100 Company News Nitto annuncia che la sperimentazione clinica di Fase 1 di NBF-006 per il trattamento dei tumori indotti dal gene KRAS nei pazienti affetti da cancro in stadio avanzato ha ricevuto l’autorizzazione a procedere dalla FDA https://www.nitto.com/eu/it/press/2018/1129.jsp Thu, 29 Nov 2018 09:00:00 +0100 Company News Announcement of Financial Results 2Q, FY2018 https://www.nitto.com/ir/library/result/ Wed, 31 Oct 2018 16:00:00 +0100 Investor Relations Auguri per il 100° anniversario https://www.nitto.com/eu/it/press/2018/1025.jsp Thu, 25 Oct 2018 08:00:00 +0100 Company News 創立100周年記念企業広告展開のお知らせ Mon, 22 Oct 2018 12:00:00 +0100 Company News Nitto Supports Reconstruction from the 2018 Hokkaido Eastern Iburi earthquake Fri, 28 Sep 2018 16:00:00 +0100 Company News 2018/Oct/31 Announcement of Financial Results for 2Q, FY2018 https://www.nitto.com/ir/calendar/ Tue, 25 Sep 2018 16:00:00 +0100 Investor Relations Nitto will be present at the Euroblech exhibition https://www.nitto.com/eu/it/topics/2018/0917.jsp Hannover, Germany, 23-26 October 2018 Mon, 17 Sep 2018 10:17:17 +0100 Trade Show Nitto will be present at the first European FOAM EXPO https://www.nitto.com/eu/it/topics/2018/0904.jsp Hannover, Germany, 16-18 October 2018 Tue, 04 Sep 2018 14:25:05 +0100 Trade Show Nitto will be present at MRO Europe 2018 https://www.nitto.com/eu/it/topics/2018/0830.jsp Amsterdam, Netherlands, 17-18 October 2018 Thu, 30 Aug 2018 08:45:27 +0100 Trade Show 滋賀事業所再開のお知らせ Sat, 11 Aug 2018 14:52:18 +0100 Company News Announcement of Financial Results 1Q, FY2018 https://www.nitto.com/ir/library/result/ Tue, 31 Jul 2018 16:00:00 +0100 Investor Relations Richiesta di approvazione di nuovo farmaco in Giappone, per la formulazione transdermica dell'antipsicotico atipico LONASEN su cerotto™ https://www.nitto.com/eu/it/press/2018/0731.jsp Tue, 31 Jul 2018 14:00:00 +0100 Company News A proposito del supporto per il ripristino dei danni causati dalle piogge torrenziali https://www.nitto.com/eu/it/press/2018/0720.jsp Fri, 20 Jul 2018 17:00:00 +0100 Company News Lo stabilimento di Onomichi ha ripreso l’attività https://www.nitto.com/eu/it/press/2018/0718.jsp Wed, 18 Jul 2018 14:48:40 +0100 Company News Effects of the Torrential Rains in July 2018 (2nd report) https://www.nitto.com/eu/it/press/2018/0715.jsp Sun, 15 Jul 2018 14:48:40 +0100 Company News Nitto will be present at the SMM exhibition https://www.nitto.com/eu/it/topics/2018/0713.jsp Hamburg, Germany, 4-7 September 2018 Fri, 13 Jul 2018 09:27:12 +0100 Trade Show Conseguenze delle piogge torrenziali di luglio 2018 https://www.nitto.com/eu/it/press/2018/0709.jsp Mon, 09 Jul 2018 18:13:42 +0100 Company News 2018/Jul/31 Announcement of Financial Results for 1Q, FY2018 https://www.nitto.com/ir/calendar/ Mon, 25 Jun 2018 16:00:00 +0100 Investor Relations Shareholders' Meeting has been updated https://www.nitto.com/ir/shareholdersmeeting/ Fri, 22 Jun 2018 17:00:00 +0100 Investor Relations Le membrane a osmosi inversa (RO) di Nitto saranno utilizzate nel primo stabilimento di desalinizzazione a doppia modalità di Singapore https://www.nitto.com/eu/it/press/2018/0620.jsp Thu, 21 Jun 2018 10:00:00 +0100 Company News Shareholders' Meeting has been updated https://www.nitto.com/ir/shareholdersmeeting/ Fri, 01 Jun 2018 17:00:00 +0100 Investor Relations Contribuire all’uso efficiente delle risorse limitate: nuovi elementi nanofiltranti per l’iniezione d’acqua nei giacimenti petroliferi (area della membrana e valori di portata più grandi del mondo) https://www.nitto.com/eu/it/press/2018/0522.jsp Thu, 31 May 2018 10:00:00 +0100 Company News Nitto avvia una partnership con MBC BioLabs per un nuovo incubatore di nuove imprese nel settore delle scienze biologiche a San Carlos https://www.nitto.com/eu/it/press/2018/0515.jsp Accelerare le innovazioni nelle scienze biologiche Tue, 15 May 2018 09:00:00 +0100 Company News Announcement of Financial Results of FY2017 https://www.nitto.com/ir/library/result/ Fri, 27 Apr 2018 16:00:00 +0100 Investor Relations Iniziative per uno stabilimento ecologico orientato al riciclo ecosostenibile https://www.nitto.com/eu/it/press/2018/0411.jsp Wed, 11 Apr 2018 10:00:00 +0100 Company News Nitto Bento wins Platinum Award for Export https://www.nitto.com/eu/it/topics/2018/0330_01.jsp Friday 23 March 2018, Istanbul (Turkey) Fri, 30 Mar 2018 15:21:52 +0100 Company News Nitto receives two certificates of recognition from Toyota Motor Europe https://www.nitto.com/eu/it/topics/2018/0330.jsp Tuesday 27 March 2018, Brussels (Belgium) Fri, 30 Mar 2018 14:43:09 +0100 Company News 2018/Apr/27 Announcement of Financial Results for Fiscal 2017 https://www.nitto.com/ir/calendar/ Mon, 26 Mar 2018 16:00:00 +0100 Investor Relations Nitto will be present at 2018 PRINT4ALL show https://www.nitto.com/eu/it/topics/2018/0326.jsp From 29 May - 01 June in Milano (Italy) Mon, 26 Mar 2018 13:45:16 +0100 Trade Show Nitto will be present at 2018 AIX show https://www.nitto.com/eu/it/topics/2018/0306.jsp From 10-12 April in Hamburg (Germany) Tue, 06 Mar 2018 10:45:53 +0100 Trade Show Richiesta IND per ND-L02-s0201 per il trattamento della fibrosi polmonare idiopatica approvata dalla FDA https://www.nitto.com/eu/it/press/2018/0305.jsp Sviluppo di ND-L02-s0201 per la fibrosi Mon, 05 Mar 2018 15:00:00 +0100 Product Announcements Nitto and Sumitomo Dainippon Pharma Announce Positive Topline Results from Phase 3 Study Evaluating Transdermal Patch Formulation of Atypical Antipsychotic LONASEN™ Wed, 14 Feb 2018 15:00:00 +0100 Product Announcements Notice of Change in Consolidated Subsidiary with Transfer of Shares https://www.nitto.com/ir/library/disclosure/ Wed, 31 Jan 2018 16:00:30 +0100 Investor Relations Resolution Regarding Share Repurchase https://www.nitto.com/ir/library/disclosure/ Wed, 31 Jan 2018 16:00:20 +0100 Investor Relations Announcement of Financial Results 3Q, FY2017 https://www.nitto.com/ir/library/result/ Wed, 31 Jan 2018 16:00:00 +0100 Investor Relations Per il settimo anno consecutivo, Nitto è stata selezionata tra i migliori 100 innovatori del mondo nell’ambito della proprietà intellettuale e dei brevetti https://www.nitto.com/eu/it/press/2018/0125.jsp 2017 Top 100 Global Innovators, il premio per i migliori innovatori del mondo Thu, 25 Jan 2018 14:00:00 +0100 Company News Una parola di ringraziamento per il vostro supporto alla Nitto ATP Finals e per il vostro rapporto sul Programma di beneficenza di Nitto https://www.nitto.com/eu/it/press/2017/1225.jsp Wed, 27 Dec 2017 13:00:00 +0100 Company News 2018/Jan/31 Announcement of Financial Results for 3Q, FY2017 https://www.nitto.com/ir/calendar/ Mon, 25 Dec 2017 16:00:00 +0100 Investor Relations